Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriana E Rosato

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Acta Biochimica Polonica|December 17, 2009
Staphylococcus aureus as an infectious agent: overview of biochemistry and molecular genetics of its pathogenicityKonrad Plata, Adriana E Rosato, Grzegorz Wegrzyn
The Journal of Antimicrobial Chemotherapy|May 22, 2009
Development of homogeneous expression of resistance in methicillin-resistant Staphylococcus aureus clinical strains is functionally associated with a beta-lactam-mediated SOS responseArabela Cuirolo, Konrad Plata, Adriana E Rosato
Antibiotics (Basel, Switzerland)|November 27, 2021
<i>Staphylococcus pseudintermedius</i>'s PBP4 Is Directly Associated with the Dissociated Oxacillin and Cefoxitin PhenotypePaula Gagetti, Roberto R Rosato, Adriana E Rosato
Journal of Bacteriology|May 20, 2003
Quantitation of mecA transcription in oxacillin-resistant Staphylococcus aureus clinical isolatesAdriana E Rosato, William A Craig, Gordon L Archer
Antimicrobial Agents and Chemotherapy|May 4, 2011
Fate of mutation rate depends on agr locus expression during oxacillin-mediated heterogeneous-homogeneous selection in methicillin-resistant Staphylococcus aureus clinical strainsKonrad B Plata, Roberto R Rosato, Adriana E Rosato
The Journal of Antimicrobial Chemotherapy|October 17, 2019
Tedizolid is a promising antimicrobial option for the treatment of Staphylococcus aureus infections in cystic fibrosis patientsMelanie Roch, Maria Celeste Varela, Agustina Taglialegna, et al.
Msphere|February 15, 2019
VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant <i>Staphylococcus aureus</i> InfectionAgustina Taglialegna, Maria C Varela, Roberto R Rosato, et al.
Antimicrobial Agents and Chemotherapy|July 16, 2014
Ceftaroline is active against heteroresistant methicillin-resistant Staphylococcus aureus clinical strains despite associated mutational mechanisms and intermediate levels of resistanceRegina Fernandez, Liliana I Paz, Roberto R Rosato, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2021
Impact of PrsA on membrane lipid composition during daptomycin-resistance-mediated β-lactam sensitization in clinical MRSA strainsCarla C C R de Carvalho, Agustina Taglialegna, Adriana E Rosato
BMC Microbiology|October 27, 2015
Impact of efflux in the development of multidrug resistance phenotypes in Staphylococcus aureusSofia Santos Costa, Miguel Viveiros, Adriana E Rosato, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Acta Biochimica Polonica|December 17, 2009
Staphylococcus aureus as an infectious agent: overview of biochemistry and molecular genetics of its pathogenicityKonrad Plata, Adriana E Rosato, Grzegorz Wegrzyn
The Journal of Antimicrobial Chemotherapy|May 22, 2009
Development of homogeneous expression of resistance in methicillin-resistant Staphylococcus aureus clinical strains is functionally associated with a beta-lactam-mediated SOS responseArabela Cuirolo, Konrad Plata, Adriana E Rosato
Antibiotics (Basel, Switzerland)|November 27, 2021
<i>Staphylococcus pseudintermedius</i>'s PBP4 Is Directly Associated with the Dissociated Oxacillin and Cefoxitin PhenotypePaula Gagetti, Roberto R Rosato, Adriana E Rosato
Journal of Bacteriology|May 20, 2003
Quantitation of mecA transcription in oxacillin-resistant Staphylococcus aureus clinical isolatesAdriana E Rosato, William A Craig, Gordon L Archer
Antimicrobial Agents and Chemotherapy|May 4, 2011
Fate of mutation rate depends on agr locus expression during oxacillin-mediated heterogeneous-homogeneous selection in methicillin-resistant Staphylococcus aureus clinical strainsKonrad B Plata, Roberto R Rosato, Adriana E Rosato
The Journal of Antimicrobial Chemotherapy|October 17, 2019
Tedizolid is a promising antimicrobial option for the treatment of Staphylococcus aureus infections in cystic fibrosis patientsMelanie Roch, Maria Celeste Varela, Agustina Taglialegna, et al.
Msphere|February 15, 2019
VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant <i>Staphylococcus aureus</i> InfectionAgustina Taglialegna, Maria C Varela, Roberto R Rosato, et al.
Antimicrobial Agents and Chemotherapy|July 16, 2014
Ceftaroline is active against heteroresistant methicillin-resistant Staphylococcus aureus clinical strains despite associated mutational mechanisms and intermediate levels of resistanceRegina Fernandez, Liliana I Paz, Roberto R Rosato, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2021
Impact of PrsA on membrane lipid composition during daptomycin-resistance-mediated β-lactam sensitization in clinical MRSA strainsCarla C C R de Carvalho, Agustina Taglialegna, Adriana E Rosato
BMC Microbiology|October 27, 2015
Impact of efflux in the development of multidrug resistance phenotypes in Staphylococcus aureusSofia Santos Costa, Miguel Viveiros, Adriana E Rosato, et al.
Pageof 5